155 related articles for article (PubMed ID: 34531225)
1. Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium.
Peñalvo JL; Genbrugge E; Mertens E; Sagastume D; van der Sande MAB; Widdowson MA; Van Beckhoven D;
BMJ Open; 2021 Sep; 11(9):e053393. PubMed ID: 34531225
[TBL] [Abstract][Full Text] [Related]
2. Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for Hypertension.
Graham DJ; Izurieta HS; Muthuri SG; Zhang D; Sandhu AT; Lu Y; Zhao Y; Feng Y; Eworuke E; Lyu H; Gandotra C; Smith ER; Avagyan A; Wernecke M; Kelman JA; Forshee RA; MaCurdy TE
J Gen Intern Med; 2021 Dec; 36(12):3802-3809. PubMed ID: 34599472
[TBL] [Abstract][Full Text] [Related]
3. Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all-cause mortality and other clinical outcomes in patients with confirmed COVID-19: A systemic review and meta-analysis.
Jia N; Zhang G; Sun X; Wang Y; Zhao S; Chi W; Dong S; Xia J; Zeng P; Liu D
J Clin Hypertens (Greenwich); 2021 Sep; 23(9):1651-1663. PubMed ID: 34320275
[TBL] [Abstract][Full Text] [Related]
4. Prescribing Trends of Renin-Angiotensin System Inhibitors and Mortality among Acute Coronary Syndrome Patients: Insights from the Malaysian National Cardiovascular Disease Registry.
Suki SZ; Zuhdi ASM; Yahya A; Adnan WAHWM; Zaharan NL
Saudi J Med Med Sci; 2024; 12(2):145-152. PubMed ID: 38764563
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive medication uses and serum ACE2 levels: ACEIs/ARBs treatment does not raise serum levels of ACE2.
Emilsson V; Gudmundsson EF; Aspelund T; Jonsson BG; Gudjonsson A; Launer LJ; Jennings LL; Gudmundsdottir V; Gudnason V
medRxiv; 2020 May; ():. PubMed ID: 32511473
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with longer survival among older medicare patients after diagnosis of supratentorial primary brain malignancies: a retrospective cohort study.
Nguyen AV; Soto JM; Digbeu BD; Nguyen CY; Wu E; Huang JH; Kuo YF
Neurol Res; 2024 May; 46(5):379-390. PubMed ID: 38415699
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and management of COVID-19-related severity in people with type 2 diabetes.
Wang B; Glicksberg BS; Nadkarni GN; Vashishth D
BMJ Open Diabetes Res Care; 2021 Sep; 9(1):. PubMed ID: 34493495
[TBL] [Abstract][Full Text] [Related]
8. Hypertension and its management in COVID-19 patients: The assorted view.
Batiha GE; Gari A; Elshony N; Shaheen HM; Abubakar MB; Adeyemi SB; Al-Kuraishy HM
Int J Cardiol Cardiovasc Risk Prev; 2021 Dec; 11():200121. PubMed ID: 34806090
[TBL] [Abstract][Full Text] [Related]
9. Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient.
García-Álvarez RM; Zapata-Cachafeiro M; Visos-Varela I; Rodríguez-Fernández A; Pintos-Rodríguez S; Piñeiro-Lamas M; Herdeiro TM; Figueiras A; Salgado-Barreira A;
Inflammopharmacology; 2024 Jun; 32(3):1805-1815. PubMed ID: 38619761
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Potential of ACEIs/ARBs Administration in Colorectal Cancer.
Wang X; Jing H
Curr Med Chem; 2024 Feb; ():. PubMed ID: 38549531
[TBL] [Abstract][Full Text] [Related]
11. Acuity level of care as a predictor of case fatality and prolonged hospital stay in patients with COVID-19: a hospital-based observational follow-up study from Pakistan.
Almas A; Mushtaq Z; Moller J
BMJ Open; 2021 May; 11(5):e045414. PubMed ID: 34049912
[TBL] [Abstract][Full Text] [Related]
12. Establishing an ad hoc COVID-19 mortality surveillance during the first epidemic wave in Belgium, 1 March to 21 June 2020.
Renard F; Scohy A; Van der Heyden J; Peeters I; Dequeker S; Vandael E; Van Goethem N; Dubourg D; De Viron L; Kongs A; Hammami N; Devleesschauwer B; Sasse A; Rebolledo Gonzalez J; Bustos Sierra N
Euro Surveill; 2021 Dec; 26(48):. PubMed ID: 34857066
[TBL] [Abstract][Full Text] [Related]
13. Joint modeling of longitudinal and competing risks for assessing blood oxygen saturation and its association with survival outcomes in COVID-19 patients.
Geraili Z; HajianTilaki K; Bayani M; Hosseini SR; Khafri S; Ebrahimpour S; Javanian M; Babazadeh A; Shokri M
J Educ Health Promot; 2024; 13():91. PubMed ID: 38726068
[TBL] [Abstract][Full Text] [Related]
14. Approximate reciprocal relationship between two cause-specific hazard ratios in COVID-19 data with mutually exclusive events.
Li W; Cetin S; Ulgen A; Cetin M; Sivgin H; Yang Y
Int J Biostat; 2024 May; 20(1):43-56. PubMed ID: 36996414
[TBL] [Abstract][Full Text] [Related]
15. Assessing type I error and power of multistate Markov models for panel data-A simulation study.
Cassarly C; Martin RH; Chimowitz M; Peña EA; Ramakrishnan V; Palesch YY
Commun Stat Simul Comput; 2017; 46(9):7040-7061. PubMed ID: 29225407
[TBL] [Abstract][Full Text] [Related]
16. Organizational characteristics: Effect on outcome of ICU COVID-19 patients in Belgium.
Patel J; Janapala RN; Belfaqeeh O; Alhashmi A; Pourmand A
Lancet Reg Health Eur; 2021 Apr; 3():100062. PubMed ID: 33870252
[No Abstract] [Full Text] [Related]
17. Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19.
Gori M; Ghirardi A; D'Elia E; Imeri G; Di Marco F; Gavazzi A; Carobbio A; Balestrieri G; Giammarresi A; Trevisan R; Amoroso M; Raimondi F; Novelli L; Magro B; Mangia G; Lorini FL; Fagiuoli S; Barbui T; Rizzi M; Cosentini R; Sironi S; Senni M;
Eur J Prev Cardiol; 2022 May; 29(5):e196-e199. PubMed ID: 34535993
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of ivermectin for the treatment of COVID-19: a systematic review and meta-analysis.
Deng J; Zhou F; Ali S; Heybati K; Hou W; Huang E; Wong CY
QJM; 2021 Dec; 114(10):721-732. PubMed ID: 34570241
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study.
Stirrup O; Boshier F; Venturini C; Guerra-Assunção JA; Alcolea-Medina A; Beckett A; Charalampous T; da Silva Filipe A; Glaysher S; Khan T; Kulasegaran Shylini R; Kele B; Monahan I; Mollett G; Parker M; Pelosi E; Randell P; Roy S; Taylor J; Weller S; Wilson-Davies E; Wade P; Williams R; ; ; Copas A; Cutino-Moguel MT; Freemantle N; Hayward AC; Holmes A; Hughes J; Mahungu T; Nebbia G; Partridge D; Pope C; Price J; Robson S; Saeed K; de Silva T; Snell L; Thomson E; Witney AA; Breuer J
BMJ Open Respir Res; 2021 Sep; 8(1):. PubMed ID: 34544733
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia in patients with COVID-19: a systematic review and meta-analysis.
Uaprasert N; Tangcheewinsirikul N; Rojnuckarin P; Patell R; Zwicker JI; Chiasakul T
Blood Adv; 2021 Nov; 5(21):4521-4534. PubMed ID: 34543382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
